Skip to content

Clinical efficacy and correlation of low frequency pulsed electrical stimulation of the common peroneal nerve in the treatment of chronic refractory wounds of the lower limb

Clinical efficacy and correlation of low frequency pulsed electrical stimulation of the common peroneal nerve in the treatment of chronic refractory wounds of the lower limb

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067503
Enrollment
Unknown
Registered
2023-01-10
Start date
2023-01-16
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic refractory wound of lower extremity

Interventions

control group:Routine wound dressing change
test group:On the basis of the control group, the common peroneal nerve low-frequency pulse electrical stimulation was given.

Sponsors

The Affiliated JiangSu Shengze Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Chronic wounds in the lower extremities (defined as the inability to heal orderly and timely within 1-2 months, resulting in anatomical and functional integrity), adults aged 18 to 80 years; 2) All types of chronic wounds, including venous ulcers (VU), diabetic foot ulcers (DFU), pressure ulcers (PU), traumatic ulcers, etc.; 3) ABI index >= 0.9 and =0.5cm2 and <=22cm2; 5) Able to comply with weekly visits to the wound and stoma clinic; 6) Able to perform microcurrent therapy at home every day; 7) Agree to participate in and sign the informed consent form for clinical research.

Exclusion criteria

Exclusion criteria: 1) Have used any microcurrent device within 6 months before the study; 2) the presence of electrical implants, such as pacemakers or neurostimulators; 3) Leg circumference or obesity (BMI > 34) not suitable for common peroneal nerve electrical stimulation equipment; 4) Malignant tumor receiving treatment or any other malignant tumor (whether in remission) involving the musculoskeletal system; 5) Suffering from multiple organ failure; 6) Systemic metabolic diseases and systemic infectious diseases; 7) Severe cognitive impairment, language impairment and non-cooperation with treatment; 8) Photocutaneous disease and systemic lupus erythematosus; 9) Severe hypertension (systolic blood pressure>180mm Hg, diastolic blood pressure>120mm Hg); 10) History of obvious blood disease or deep vein thrombosis or coagulation dysfunction or recent use of anticoagulants in the previous 6 months; 11) Acute dysplasia; 12) Patients receiving immunosuppressants, hormones and other drugs that affect wound healing; 13) Pregnancy

Design outcomes

Primary

MeasureTime frame
Wound area reduction rate;

Secondary

MeasureTime frame
Bates-Jensen Wound Status Score (BWAT);Visual Analogue Pain (VAS) Score;Lower extremity chronic wound quality of life rating scale WOUND-QOL;Quality of Life Questionnaire for Patients with Lower Extremity Venous Ulcers (VLU-QOL);Midkine;Wound microbes;

Countries

China

Contacts

Public ContactLu Qian

The Affiliated JiangSu Shengze Hospital of Nanjing Medical University

luqian424@126.com15952087698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026